Microneedles Could Replace Syringe

The common needle phobia and painful injections could soon be a thing of the past, thanks to a revolutionary new drug-delivery technique developed by a team at the Georgia Institute of Technology, US. The long-practiced method of drug administration has up to now involved the use of hypodermic needles but they have many drawbacks, including pain, risk of infection, and the need for trained staff to perform the injection.

The very few non-invasive methods of drug delivery, such as the transdermal patch, best known in its role as the smokers' nicotine patch, are unsuitable for most drugs as only very small molecules can be transported across intact skin, which excludes the large biotherapeutic molecules found in many medicines.

But what if there was another way, one that was as safe and painless as a patch but as fast and effective as an injection? In a revolutionary new study published in this month's Advanced Materials, the researchers at Georgia Tech. have designed tiny "microneedles", only five micrometers wide at the tip, which can quickly and painlessly deliver drugs into the body and are as effective as a hypodermic.

The drug, in the form of biomolecules, is encapsulated within the microneedles, which are then inserted into the skin in the same way that nicotine is released into the bloodstream from a patch. The needles dissolve within minutes, releasing the trapped cargo at the intended delivery site. They do not need to be removed and no dangerous or biohazardous substance is left behind on the skin.

The researchers chose the mechanically strong polymer poly(vinyl pyrrolidone) (PVP) to fabricate the microneedles because it is robust enough to pierce the skin, dissolves quickly, and is harmless to the body. The molding technique used to prepare the needles means that the rate at which they dissolve can be precisely tuned, depending on how much time is needed for them to travel through the body to the delivery site.

This innovative new treatment method means that vaccines, proteins, and hormones could soon be delivered into the body as effortlessly and painlessly as wearing a plaster. So could needle phobia soon be a thing of the past?

"We expect that microneedles will be able to replace hypodermic needles in some scenarios, but certainly not all cases," said Dr. Mark Prausnitz, who headed up the research. "They won't be useful for withdrawing significant quantities of blood for analysis, for example."

However, the team does expect that the microneedles will have important medical and biotechnology applications. "They are a useful way to deliver vaccines," explained Prausnitz. "Microneedles could possibly enable self-administration of the annual flu vaccine and a number of drugs, including insulin and growth hormone."

Article information: Advanced Materials, 2008, 20, 933; doi: 10.1002/adma.200701205

Source: by Sophie Ladden, Wiley

Related stories:

Microneedles enhance drug administration through skin
In what is believed to be the first peer-reviewed study of its kind involving human subjects, researchers at the University of Kentucky College of Pharmacy and the Georgia Institute of Technology have demonstrated that patches coated on one side with microscopic needles can facilitate transdermal delivery of clinically-relevant doses of a drug that normally cannot pass through the skin.
Ceramic hybrid needles take the sting out of shots
New polymerization technology may one day take the pain out of injections and blood draws. A team of researchers at the University of North Carolina and Laser Zentrum Hannover have recently used two-photon polymerization to create hollow needles so fine patients wouldn’t feel them piercing their skin. Clustered together on a patch, these microneedles can deliver drugs or draw blood efficiently as standard hypodermic needles. These findings are reported in the International Journal of Applied Ceramic Technology.
Microneedles: Flu Vaccine in Painless Skin Patches under Development
Flu vaccine delivered through painless microneedles in patches applied to the skin could soon be an alternative to delivery through hypodermic needles, according to researchers at Emory University and the Georgia Institute of Technology in Atlanta. Using new grants from the National Institutes of Health (NIH) totaling approximately $11.5 million over five years, researchers from the two institutions plan to develop a new vaccine product using the microscopic needles.
Cell division study resolves 50-year-old-debate, may aid cancer research
A new study at Oregon State University has finally resolved a controversy that cellular biologists have been arguing over for nearly 50 years, with findings that may aid research on everything from birth defects and genetic diseases to the most classic "cell division" issue of them all – cancer.
Plucking comet dust from Stardust collectors
Ever since NASA's Stardust spacecraft delivered a payload of comet dust to Earth on Jan. 15, 2006, scientists by the hundreds have been clamoring for samples.

News discussion:

Physics news